Former Schroders manager joins in July
Running sessions throughout June's inaugural event
Fund will be classified as Article 9 under SFDR
White and Robertson to lead management
Fund will consist of 30-50 holdings
CEO Fink pledges more action on diversity
Overall shareholder base voted to maintain £201m trust
Main focus on pharma and biotech
Manager of £1.2bn fund leaving in Q2